Private company
DOV Pharmaceutical
Biotechnology company acquired in 2010
DOV Pharmaceutical was a biotechnology company that focused on therapies primarily for central nervous system conditions. It was founded in 1995 by former employees of American Cyanamid (which was acquired by Wyeth in 1994), and in 1998 it in-licensed drugs discovered at American Cyanamid for further development. It held an IPO on NASDQ in 2002, and its shares plunged days later after negative details about a past relationship between Élan and DOV emerged.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
See how the biggest companies compare on our leaderboards
DOV Pharmaceutical was a biotechnology company that focused on therapies primarily for central nervous system conditions. It was founded in 1995 by former employees of American Cyanamid (which was acquired by Wyeth in 1994), and in 1998 it in-licensed drugs discovered at American Cyanamid for further development. It held an IPO on NASDQ in 2002, and its shares plunged days later after negative details about a past relationship between Élan and DOV emerged.2
Links
- WikipediaDOV Pharmaceutical
- WikidataQ5205906
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataDOV Pharmaceutical on Wikidata
- 2WikipediaDOV Pharmaceutical on Wikipedia